ArticleEuropean journal of nuclear medicine and molecular imaging2014
Staging the axilla in breast cancer patients with ¹⁸F-FDG PET: how small are the metastases that we can detect with new generation clinical PET systems?
Article in European journal of nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Joint EANM-SNMMI guideline on the role of 2-[European journal of nuclear medicine and molecular imaging · 2024Guideline
- Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis.European journal of nuclear medicine and molecular imaging · 2017Pooled it
- A comparative study of dual-layer spectral CT and 18F-FDG-PET/CT multi-quantitative parameters in the diagnosis of sentinel lymph nodes in breast cancer.Annals of nuclear medicine · 2025Article
- Diagnostic accuracy of dual-phaseScientific reports · 2025Article
- [Insights into imaging · 2024Article
- Phantom and clinical evaluation of the Bayesian penalised likelihood reconstruction algorithm Q.Clear without PSF correction in amyloid PET images.EJNMMI physics · 2024Article
- Deep learning study on the mechanism of edge artifacts in point spread function reconstruction for numerical brain images.Annals of nuclear medicine · 2023Article
- A nomogram for predicting three or more axillary lymph node involvement before breast cancer surgery.Scientific reports · 2022Article
- Is it time to include [European journal of nuclear medicine and molecular imaging · 2021Article
- Lymph Node Staging with a Combined Protocol ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021Article
- New PET technologies - embracing progress and pushing the limits.European journal of nuclear medicine and molecular imaging · 2021Article
- Hormonal Receptor Immunochemistry Heterogeneity andFrontiers in oncology · 2020Article
- Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics.EJNMMI research · 2018Article
- Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria.EJNMMI physics · 2018Article
- Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neckEJNMMI research · 2018Article
- Diagnostic performance ofCancer imaging : the official publication of the International Cancer Imaging Society · 2018Article
- Diagnostic implications of a small-voxel reconstruction for loco-regional lymph node characterization in breast cancer patients using FDG-PET/CT.EJNMMI research · 2018Article
- EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.EJNMMI physics · 2017Article
- EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.European journal of nuclear medicine and molecular imaging · 2017Review
- Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.European journal of nuclear medicine and molecular imaging · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePoint spread function (PSF) reconstruction improves spatial resolution throughout the entire field of view of a PET system and can detect smaller metastatic deposits than conventional algorithms such as OSEM. We assessed the impact of PSF reconstruction on quantitative values and diagnostic accuracy for axillary staging of breast cancer patients, compared with an OSEM reconstruction, with emphasis on the size of nodal metastases.
methodsThis was a prospective study in a single referral centre in which 50 patients underwent an (18)F-FDG PET examination before axillary lymph node dissection. PET data were reconstructed with an OSEM algorithm and PSF reconstruction, analysed blindly and validated by a pathologist who measured the largest nodal metastasis per axilla. This size was used to evaluate PET diagnostic performance.
resultsOn pathology, 34 patients (68%) had nodal involvement. Overall, the median size of the largest nodal metastasis per axilla was 7 mm (range 0.5 - 40 mm). PSF reconstruction detected more involved nodes than OSEM reconstruction (p = 0.003). The mean PSF to OSEM SUVmax ratio was 1.66 (95 % CI 1.01 - 2.32). The sensitivities of PSF and OSEM reconstructions were, respectively, 96% and 92% in patients with a largest nodal metastasis of >7 mm, 60% and 40% in patients with a largest nodal metastasis of ≤7 mm, and 92% and 69% in patients with a primary tumour ≤30 mm. Biggerstaff graphical comparison showed that globally PSF reconstruction was superior to OSEM reconstruction. The median sizes of the largest nodal metastasis in patients with nodal involvement not detected by either PSF or OSEM reconstruction, detected by PSF but not by OSEM reconstruction and detected by both reconstructions were 3, 6 and 16 mm (p = 0.0064) respectively. In patients with nodal involvement detected by PSF reconstruction but not by OSEM reconstruction, the smallest detectable metastasis was 1.8 mm.
conclusionAs a result of better activity recovery, PET with PSF reconstruction performed better than PET with OSEM reconstruction in detecting nodal metastases ≤7 mm. However, its sensitivity is still insufficient for it to replace surgical approaches for axillary staging. PET with PSF reconstruction could be used to perform sentinel node biopsy more safely in patients with a primary tumour ≤30 mm and with unremarkable PET results in the axilla.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.